Dimensional Fund Advisors
BCDA icon

Dimensional Fund Advisors’s BioCardia BCDA Stock Holding History

Dimensional Fund Advisors’s Portfolio BCDA Stock Details BCDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,827
Closed -$53K – 3493
2022
Q3 		$53K Hold
1,827
– – ﹤0.01% 3398
2022
Q2 		$41K Hold
1,827
– – ﹤0.01% 3408
2022
Q1 		$57K Buy
+1,827
New +$54.3K ﹤0.01% 3447

Other funds holding BCDA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return
FM
Family Management New York $834M AUM 20.83% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Dimensional Fund Advisors's BCDA Position: Q4 2022 in Review

Dimensional Fund Advisors sold out of BioCardia (BCDA) in Q4 2022, closing a stake of 1,827 shares — an estimated $53K sold.

Dimensional Fund Advisors first reported a position in BCDA in Q1 2022 and held it in 3 quarters. The position peaked at $57K in Q1 2022. 25 funds tracked by Wall St. Rank hold BCDA as of Q4 2022.

  • Dimensional Fund Advisors reported no remaining BioCardia position as of Q4 2022 after selling out during the quarter.
  • Dimensional Fund Advisors sold 1,827 BioCardia shares in Q4 2022, an estimated $53K.
  • Dimensional Fund Advisors first reported a position in BioCardia in Q1 2022 and held it in 3 quarters.
  • Dimensional Fund Advisors's BioCardia position peaked at $57K in Q1 2022.
  • 25 funds tracked by Wall St. Rank held BioCardia as of Q4 2022.

Based on Dimensional Fund Advisors's 13F filing for Q4 2022, filed 9 Feb 2023.